249 related articles for article (PubMed ID: 28632785)
41. Determinants of serum cotinine and hair cotinine as biomarkers of childhood secondhand smoke exposure.
Kalkbrenner AE; Hornung RW; Bernert JT; Hammond SK; Braun JM; Lanphear BP
J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):615-24. PubMed ID: 20237497
[TBL] [Abstract][Full Text] [Related]
42. [Environmental tobacco smoke exposure in pregnancy and postpartum period].
Polańska K; Hanke W; Sobala W; Ligocka D; Lowe J
Przegl Lek; 2006; 63(10):907-10. PubMed ID: 17288181
[TBL] [Abstract][Full Text] [Related]
43. Biomarkers of exposure to passive smoking of school children: frequency and determinants.
Thaqi A; Franke K; Merkel G; Wichmann HE; Heinrich J
Indoor Air; 2005 Oct; 15(5):302-10. PubMed ID: 16108902
[TBL] [Abstract][Full Text] [Related]
44. Stimulated and non-stimulated saliva as biological material in the assessment of cotinine concentration.
Bachaneki T; Nakonieczna-Rudnicka M; Piekarczyk W
Przegl Lek; 2015; 72(10):493-5. PubMed ID: 26946552
[TBL] [Abstract][Full Text] [Related]
45. [Biomarkers of tobacco smoke exposure].
Berny C; Boyer JC; Capolaghi B; De L'Homme G; Desch G; Garelik D; Hayder R; Houdret N; Jacob N; Koskas T; Lainé G; Le Moel G; Moulsma M; Plantin-Carrenard E; Venembre P
Ann Biol Clin (Paris); 2002; 60(3):263-72. PubMed ID: 12050041
[TBL] [Abstract][Full Text] [Related]
46. Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers.
Yamagishi S; Matsui T; Nakamura K
Med Hypotheses; 2008 Aug; 71(2):259-61. PubMed ID: 18448262
[TBL] [Abstract][Full Text] [Related]
47. Nicotine depedence and salivary cotinine concentration in daily smokers.
Fu M; Martínez-Sánchez JM; Agudo A; Pascual JA; Ariza C; Moncada A; Fernández E;
Eur J Cancer Prev; 2012 Jan; 21(1):96-102. PubMed ID: 22129659
[TBL] [Abstract][Full Text] [Related]
48. Serum 25-hydroxyvitamin D
Chen J; van der Duin D; Campos-Obando N; Ikram MA; Nijsten TEC; Uitterlinden AG; Zillikens MC
Eur J Epidemiol; 2019 Jan; 34(1):67-77. PubMed ID: 30255328
[TBL] [Abstract][Full Text] [Related]
49. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations.
Da Moura Semedo C; Webb M; Waller H; Khunti K; Davies M
Postgrad Med J; 2017 May; 93(1099):289-294. PubMed ID: 28143896
[TBL] [Abstract][Full Text] [Related]
50. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
Yue X; Hu H; Koetsier M; Graaff R; Han C
Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
[TBL] [Abstract][Full Text] [Related]
51. Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.
Kellow NJ; Coughlan MT; Reid CM
Eur J Nutr; 2018 Sep; 57(6):2209-2216. PubMed ID: 28656390
[TBL] [Abstract][Full Text] [Related]
52. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
[TBL] [Abstract][Full Text] [Related]
53. Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination.
Agewall S; Persson B; Lindstedt G; Fagerberg B
Br J Biomed Sci; 2002; 59(3):145-9. PubMed ID: 12371055
[TBL] [Abstract][Full Text] [Related]
54. Validation of Urinary Thiocyanate as a Robust Biomarker of Active Tobacco Smoking in the Prospective Urban and Rural Epidemiological Study.
Mathiaparanam S; Gill B; Sathish T; Paré G; Teo KK; Yusuf S; Britz-McKibbin P
Nicotine Tob Res; 2023 Jun; 25(7):1291-1301. PubMed ID: 36960777
[TBL] [Abstract][Full Text] [Related]
55. Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.
Benowitz NL; Dains KM; Dempsey D; Yu L; Jacob P
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1160-6. PubMed ID: 20447913
[TBL] [Abstract][Full Text] [Related]
56. Determinants of salivary cotinine level: a population-based study in Brazil.
Figueiredo VC; Szklo M; Szklo AS; Benowitz N; Lozana JA; Casado L; Masson E; Samet J
Rev Saude Publica; 2007 Dec; 41(6):954-62. PubMed ID: 17992352
[TBL] [Abstract][Full Text] [Related]
57. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus.
Garay-Sevilla ME; Regalado JC; Malacara JM; Nava LE; Wróbel-Zasada K; Castro-Rivas A; Wróbel K
J Endocrinol Invest; 2005 Mar; 28(3):223-30. PubMed ID: 15952406
[TBL] [Abstract][Full Text] [Related]
58. Passive smoking assessed by salivary cotinine and self-report in relation to cause-specific mortality: 17-year follow-up of study participants in the UK Health and Lifestyle Survey.
Batty GD; Gale CR; Jefferis B; Kvaavik E
J Epidemiol Community Health; 2014 Dec; 68(12):1200-3. PubMed ID: 25138392
[TBL] [Abstract][Full Text] [Related]
59. Serum cotinine levels and diabetes mellitus in never smokers.
Alshaarawy O; Elbaz HA
J Diabetes Complications; 2015; 29(8):1032-6. PubMed ID: 26382617
[TBL] [Abstract][Full Text] [Related]
60. Self-Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End-Stage Disease) Prospective Cohort Study.
Kunutsor SK; Spee JM; Kieneker LM; Gansevoort RT; Dullaart RPF; Voerman AJ; Touw DJ; Bakker SJL
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
